Framingham, MA – April 14, 2023. Kephera Diagnostics announced today, on World Chagas Day, that it will be launching testing for Chagas disease through its CLIA-certified laboratory in May 2023. Kephera will offer two tests – an FDA-approved ELISA and a new, multiplex test for Chagas disease – both of which detect antibodies to the…
Framingham, MA – April 3, 2023. The National Institute of Allergy and Infectious Diseases (NIAID), an agency of the National Institutes of Health (NIH), has awarded a Phase II, $3,050,000 Small Business Innovative Research (SBIR) grant to Kephera Diagnostics to complete the development of a new rapid, point-of-care test for Chagas disease, the company announced…
Framingham, MA – March 28, 2023. The National Institute of Allergy and Infectious Diseases (NIAID), an agency of the National Institutes of Health (NIH), has awarded a Phase I, $600,000 Small Business Innovative Research (SBIR) grant to Kephera Diagnostics to develop a test for hookworm infection, the company announced today. The grant will support the…